loder
Start Typing

Here, you can select the report, if matching with your text

Global Next-Generation Antibody Therapeutics Market

Next-Generation Antibody Therapeutics Market - Type: Monoclonal Antibodies, Bispecific Antibodies, Antibody-Drug Conjugates; By Application: Oncology, Autoimmune Diseases, Infectious Diseases; By End User: Pharmaceutical Companies, Biotechnology Companies, Research Institutes; By Technology: Recombinant DNA Technology, Hybridoma Technology, Phage Display Technology; By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies; By Region: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Report Code
CVMI24071883
Published
July 16, 2024
Last Updated
July 16, 2024
Coverage
Healthcare • Biotechnology
Buy Report $3600.00 single user Speak To An Analyst
Analyst-led, consultative delivery
Enterprise-ready licensing options
Fast turnarounds for custom cuts

Market Snapshot

High-signal KPIs designed for executive scanning.
Indicative snapshot. Request sample for full model outputs.
Market Size (latest)
—
— vs. prior year
CAGR
—
Forecast window: —
Forecast Period
2024–2031
Base years: 2019–2023
Coverage Depth
—
Segments • Regions • Players

Insights

Consultative narrative + actionable decision support.
nan
nan
nan

Key Players

  • Genmab
  • ImmunoGen
  • MacroGenics
  • Amgen
  • Regeneron Pharmaceuticals
Competitive Dashboard Preview
Shortlist strategic accounts and benchmark positioning.
Loading…
Request Competitive Cut

Segmentation Explorer

Interactively explore markets by segment and geography.
Refine View
—
Request A Custom Cut
Opportunity Index
Directional signals for prioritization and scenario framing.
Interactive
Need a board-ready slide? .
Modeling inputs: analyst assumptions, secondary sources, triangulated validations.

Table Of Contents

Expandable preview of coverage and chapter structure.
Global Next-Generation Antibody Therapeutics Market Report

Global Next-Generation Antibody Therapeutics Market Report

    1. Global Next-Generation Antibody Therapeutics Market Research Report
    1. 1.1 Study Objectives
    2. 1.2 Global Next-Generation Antibody Therapeutics Market - Overview
    3. 1.3 Reason to Read This Report
    4. 1.4 Methodology and Forecast Analysis
    2. Global Next-Generation Antibody Therapeutics Market Research Report - Preface
    1. 2.1 Global Next-Generation Antibody Therapeutics Market Research Report – Detailed Scope and Definitions
      1. 2.1.1 By Type
      2. 2.1.2 By Application
      3. 2.1.3 By End User
      4. 2.1.4 By Technology
      5. 2.1.5 By Distribution Channel
      6. 2.1.6 By Region
    3. Global Next-Generation Antibody Therapeutics Market Dynamics
    1. 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
    2. 3.2. Restraints – By Type, By Application, By End User, By Technology, By Distribution Channel, By Country
    3. 3.3. Opportunities – By Type, By Application, By End User, By Technology, By Distribution Channel, By Country
    4. 3.4. Trends – By Type, By Application, By End User, By Technology, By Distribution Channel, By Country
    5. 3.5. PEST Analysis
    6. 3.6. Porters Five Rule Analysis
    7. 3.7. Company’s Share Analysis (CSA) by Region or By Country
    8. 3.8. Global Next-Generation Antibody Therapeutics Market Research Report – DROTs Impact Analysis
    4. Global Next-Generation Antibody Therapeutics Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
    1. 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    2. 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
    3. 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
    4. 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. Global Next-Generation Antibody Therapeutics Market, By Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 5.1 Monoclonal Antibodies
      1. 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 5.2 Bispecific Antibodies
      1. 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 5.3 Antibody-Drug Conjugates
      1. 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. Global Next-Generation Antibody Therapeutics Market, By Application, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 6.1 Oncology
      1. 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 6.2 Autoimmune Diseases
      1. 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 6.3 Infectious Diseases
      1. 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    7. Global Next-Generation Antibody Therapeutics Market, By End User, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 7.1 Pharmaceutical Companies
      1. 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 7.2 Biotechnology Companies
      1. 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 7.3 Research Institutes
      1. 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    8. Global Next-Generation Antibody Therapeutics Market, By Technology, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 8.1 Recombinant DNA Technology
      1. 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 8.2 Hybridoma Technology
      1. 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 8.3 Phage Display Technology
      1. 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    9. Global Next-Generation Antibody Therapeutics Market, By Distribution Channel, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 9.1 Hospital Pharmacies
      1. 9.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 9.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 9.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 9.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 9.2 Retail Pharmacies
      1. 9.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 9.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 9.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 9.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 9.3 Online Pharmacies
      1. 9.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 9.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 9.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 9.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    10. Global Next-Generation Antibody Therapeutics Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
    1. 10.1 North America
      1. 10.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 10.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 10.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 10.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 10.2 Europe
      1. 10.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 10.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 10.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 10.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 10.3 Asia-Pacific
      1. 10.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 10.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 10.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 10.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    4. 10.4 Latin America
      1. 10.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 10.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 10.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 10.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. 10.5 Middle East & Africa
      1. 10.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 10.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 10.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 10.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      6. 10.6 Global Next-Generation Antibody Therapeutics Market - Opportunity Analysis Index, By Type, By Application, By End User, By Technology, By Distribution Channel, and Region, 2024 - 2031
    11. North America Global Next-Generation Antibody Therapeutics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
      11.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.1.1 Monoclonal Antibodies
      2. 11.1.2 Bispecific Antibodies
      3. 11.1.3 Antibody-Drug Conjugates
      11.2 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.2.1 Oncology
      2. 11.2.2 Autoimmune Diseases
      3. 11.2.3 Infectious Diseases
      11.3 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.3.1 Pharmaceutical Companies
      2. 11.3.2 Biotechnology Companies
      3. 11.3.3 Research Institutes
      11.4 By Technology Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.4.1 Recombinant DNA Technology
      2. 11.4.2 Hybridoma Technology
      3. 11.4.3 Phage Display Technology
      11.5 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.5.1 Hospital Pharmacies
      2. 11.5.2 Retail Pharmacies
      3. 11.5.3 Online Pharmacies
      11.6 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.6.1 United States
      2. 11.6.2 Canada
      11.7 North America Global Next-Generation Antibody Therapeutics Market – Opportunity Analysis Index, By Type, By Application, By End User, By Technology, By Distribution Channel, and Country, 2024 - 2031
      11.8 Regional Trends Analysis
      11.9 North America Global Next-Generation Antibody Therapeutics Market Research Report - Company Profiles
      1. 11.9.1 Company 1 (United States)
      2. 11.9.2 Company 2 (Canada)
      3. 11.9.3 Company 3 (Canada)
    12. Europe Global Next-Generation Antibody Therapeutics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
      12.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.1.1 Monoclonal Antibodies
      2. 12.1.2 Bispecific Antibodies
      3. 12.1.3 Antibody-Drug Conjugates
      12.2 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.2.1 Oncology
      2. 12.2.2 Autoimmune Diseases
      3. 12.2.3 Infectious Diseases
      12.3 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.3.1 Pharmaceutical Companies
      2. 12.3.2 Biotechnology Companies
      3. 12.3.3 Research Institutes
      12.4 By Technology Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.4.1 Recombinant DNA Technology
      2. 12.4.2 Hybridoma Technology
      3. 12.4.3 Phage Display Technology
      12.5 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.5.1 Hospital Pharmacies
      2. 12.5.2 Retail Pharmacies
      3. 12.5.3 Online Pharmacies
      12.6 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.6.1 Germany
      2. 12.6.2 United Kingdom
      3. 12.6.3 France
      4. 12.6.4 Spain
      5. 12.6.5 Italy
      6. 12.6.6 Russia
      7. 12.6.7 Netherlands
      8. 12.6.8 Poland
      9. 12.6.9 Rest of Europe
      12.7 Europe Global Next-Generation Antibody Therapeutics Market – Opportunity Analysis Index, By Type, By Application, By End User, By Technology, By Distribution Channel, and Country, 2024 - 2031
      12.8 Regional Trends Analysis
      12.9 Europe Global Next-Generation Antibody Therapeutics Market Research Report - Company Profiles
      1. 12.9.1 Company 1 (Germany)
      2. 12.9.2 Company 2 (United Kingdom)
      3. 12.9.3 Company 3 (United Kingdom)
    13. Asia-Pacific Global Next-Generation Antibody Therapeutics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
      13.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.1.1 Monoclonal Antibodies
      2. 13.1.2 Bispecific Antibodies
      3. 13.1.3 Antibody-Drug Conjugates
      13.2 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.2.1 Oncology
      2. 13.2.2 Autoimmune Diseases
      3. 13.2.3 Infectious Diseases
      13.3 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.3.1 Pharmaceutical Companies
      2. 13.3.2 Biotechnology Companies
      3. 13.3.3 Research Institutes
      13.4 By Technology Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.4.1 Recombinant DNA Technology
      2. 13.4.2 Hybridoma Technology
      3. 13.4.3 Phage Display Technology
      13.5 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.5.1 Hospital Pharmacies
      2. 13.5.2 Retail Pharmacies
      3. 13.5.3 Online Pharmacies
      13.6 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.6.1 China
      2. 13.6.2 Japan
      3. 13.6.3 India
      4. 13.6.4 South Korea
      5. 13.6.5 Australia & NZ
      6. 13.6.6 ASEAN
      7. 13.6.7 Rest of Asia-Pacific
      13.7 Asia-Pacific Global Next-Generation Antibody Therapeutics Market – Opportunity Analysis Index, By Type, By Application, By End User, By Technology, By Distribution Channel, and Country, 2024 - 2031
      13.8 Regional Trends Analysis
      13.9 Asia-Pacific Global Next-Generation Antibody Therapeutics Market Research Report - Company Profiles
      1. 13.9.1 Company 1 (China)
      2. 13.9.2 Company 2 (Japan)
      3. 13.9.3 Company 3 (Japan)
    14. Latin America Global Next-Generation Antibody Therapeutics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
      14.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 14.1.1 Monoclonal Antibodies
      2. 14.1.2 Bispecific Antibodies
      3. 14.1.3 Antibody-Drug Conjugates
      14.2 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 14.2.1 Oncology
      2. 14.2.2 Autoimmune Diseases
      3. 14.2.3 Infectious Diseases
      14.3 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 14.3.1 Pharmaceutical Companies
      2. 14.3.2 Biotechnology Companies
      3. 14.3.3 Research Institutes
      14.4 By Technology Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 14.4.1 Recombinant DNA Technology
      2. 14.4.2 Hybridoma Technology
      3. 14.4.3 Phage Display Technology
      14.5 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 14.5.1 Hospital Pharmacies
      2. 14.5.2 Retail Pharmacies
      3. 14.5.3 Online Pharmacies
      14.6 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 14.6.1 Brazil
      2. 14.6.2 Mexico
      3. 14.6.3 Argentina
      4. 14.6.4 Peru
      5. 14.6.5 Colombia
      6. 14.6.6 Rest of Latin America
      14.7 Latin America Global Next-Generation Antibody Therapeutics Market – Opportunity Analysis Index, By Type, By Application, By End User, By Technology, By Distribution Channel, and Country, 2024 - 2031
      14.8 Regional Trends Analysis
      14.9 Latin America Global Next-Generation Antibody Therapeutics Market Research Report - Company Profiles
      1. 14.9.1 Company 1 (Brazil)
      2. 14.9.2 Company 2 (Mexico)
      3. 14.9.3 Company 3 (Mexico)
    15. Middle East & Africa Global Next-Generation Antibody Therapeutics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
      15.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 15.1.1 Monoclonal Antibodies
      2. 15.1.2 Bispecific Antibodies
      3. 15.1.3 Antibody-Drug Conjugates
      15.2 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 15.2.1 Oncology
      2. 15.2.2 Autoimmune Diseases
      3. 15.2.3 Infectious Diseases
      15.3 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 15.3.1 Pharmaceutical Companies
      2. 15.3.2 Biotechnology Companies
      3. 15.3.3 Research Institutes
      15.4 By Technology Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 15.4.1 Recombinant DNA Technology
      2. 15.4.2 Hybridoma Technology
      3. 15.4.3 Phage Display Technology
      15.5 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 15.5.1 Hospital Pharmacies
      2. 15.5.2 Retail Pharmacies
      3. 15.5.3 Online Pharmacies
      15.6 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 15.6.1 Saudi Arabia
      2. 15.6.2 UAE
      3. 15.6.3 South Africa
      4. 15.6.4 Egypt
      5. 15.6.5 Israel
      6. 15.6.6 Rest of Middle East and Africa
      15.7 Middle East & Africa Global Next-Generation Antibody Therapeutics Market – Opportunity Analysis Index, By Type, By Application, By End User, By Technology, By Distribution Channel, and Country, 2024 - 2031
      15.8 Regional Trends Analysis
      15.9 Middle East & Africa Global Next-Generation Antibody Therapeutics Market Research Report - Company Profiles
      1. 15.9.1 Company 1 (Saudi Arabia)
      2. 15.9.2 Company 2 (UAE)
      3. 15.9.3 Company 3 (UAE)
    16. Competition Landscape
      16.1 Strategic Dashboard of Top Market Players
      16.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
      1. 16.2.1 Genmab
      2. 16.2.2 ImmunoGen
      3. 16.2.3 MacroGenics
      4. 16.2.4 Amgen
      5. 16.2.5 Regeneron Pharmaceuticals
    17. Data Collection Method and Research Approach
    18. Principal Presumptions and Acronyms

Methodology & Credibility

Built for enterprise decisions, not vanity metrics.
Triangulated Sizing
Bottom-up, top-down, and peer benchmarks reconciled by analysts.
Primary + Secondary Research
Executive interviews combined with validated public and paid sources.
Scenario & Sensitivity
Base, bull and bear cases to stress-test strategic moves.
Need Confidence Fast?
We’ll map your questions to the report in 15 minutes.
Book A Consultation
Preferred by strategy, marketing, and corporate development teams.

Related Reports

More coverage in adjacent themes and segments.
Global Advanced Musculoskeletal Care Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report
CVMI30116 Dec. 1, 2025
$3600.00 single user
View report →
Global Under-Arm Exoskeletons Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report
CVMI0112 Dec. 1, 2025
$3600.00 single user
View report →
Global LED Lip Masks Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report
CVMI30115 Dec. 1, 2025
$3600.00 single user
View report →
Global Light-Powered Joint Support Systems Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report
CVMI30114 Nov. 30, 2025
$3600.00 single user
View report →
Global Dual Microcurrent Devices Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report
CVMI30113 Nov. 30, 2025
$3600.00 single user
View report →
Global Wearable Medical-Grade Cold Lasers Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report
CVMI3011 Nov. 30, 2025
$3600.00 single user
View report →
Global Wearable Light Therapy Devices Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report
CVMI30112 Nov. 30, 2025
$3600.00 single user
View report →
Global Targeted Air Compression Therapies Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report
CVMI2711 Nov. 27, 2025
$3600.00 single user
View report →
Global Wearable Light-Emitting Diodes (LEDs) Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report
CVMI27111 Nov. 27, 2025
$3600.00 single user
View report →
Global Robotic Hand Assistance Solutions Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report
CVMI2611 Nov. 26, 2025
$3600.00 single user
View report →
Istanbul Hair Transplant Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report
CVMI26081 Aug. 26, 2025
$3600.00 single user
View report →
Global Osteo-Odonto-Keratoprosthesis (OOKP) Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report
CVMI1008 Aug. 10, 2025
$3600.00 single user
View report →
Ready to move from data to decision?
Get the report, request a sample, or book a consultative briefing.
Buy Report Talk To An Analyst
New chat message received
×

Need help?

Chat with our team in a minute.
We usually reply within a few minutes.